By the time we observe lumen filling lesions, or in HER2-overexpressing breast cancer cells, basolateral polarization is lost and HER2, Ezrin, NHERF1, HSP90, and Erbin all join together to form stable signaling complexes that localize within protruding membrane domains. Here, ERBIN is linked to breast cancer.